Sec. 6. Changes relating to National Institute of Diabetes and Digestive and Kidney Diseases
1,292 words·~6 min read·
/bill/116/s/3074/is/section-6A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Subpart 3 of part C of title IV of the Public Health Service Act ( 42 U.S.C. 285c et seq.) is amended in the subpart heading by striking and inserting National Institute of Diabetes and Digestive and Kidney Diseases . National Institute of Diabetes and Digestive, Kidney, and Liver Diseases The individual serving as the Director of the National Institute of Diabetes and Digestive and Kidney Diseases as of the date of enactment of this Act may continue to serve as the Director of the National Institute of Diabetes and Digestive, Kidney, and Liver Diseases commencing as of that date.
Any reference to the National Institute of Diabetes and Digestive and Kidney Diseases, or the Director of the National Institute of Diabetes and Digestive and Kidney Diseases, in any law, regulation, document, record, or other paper of the United States shall be deemed to be a reference to the National Institute of Diabetes and Digestive, Kidney, and Liver Diseases, or the Director of the National Institute of Diabetes and Digestive, Kidney, and Liver Diseases, respectively. Section 401(b)(3) of the Public Health Service Act ( 42 U.S.C. 281(b)(3) ) is amended by striking The National Institute of Diabetes and Digestive and Kidney Diseases. and inserting The National Institute of Diabetes and Digestive, Kidney, and Liver Diseases. .
Section 409A(a) of the Public Health Service Act ( 42 U.S.C. 284e(a) ) is amended by striking the National Institute of Diabetes and Digestive and Kidney Diseases and inserting the National Institute of Diabetes and Digestive, Kidney, and Liver Diseases . Section 426 of the Public Health Service Act ( 42 U.S.C. 285c ) is amended— by striking National Institute of Diabetes and Digestive and Kidney Diseases and inserting National Institute of Diabetes and Digestive, Kidney, and Liver Diseases ; and by striking and kidney, urologic, and hematologic diseases and inserting kidney, urologic, and hematologic diseases, and liver diseases .
Section 427 of the Public Health Service Act ( 42 U.S.C. 285c–1 ) is amended by adding at the end the following new subsection: The Director of the Institute shall
(1)establish the National Liver Diseases Data System for the collection, storage, analysis, retrieval, and dissemination of data derived from patient populations with liver diseases, including, where possible, data involving general populations for the purpose of detection of individuals with a risk of developing liver diseases, and
(2)establish the National Liver Diseases Information Clearinghouse to facilitate and enhance knowledge and understanding of liver diseases on the part of health professionals, patients, and the public through the effective dissemination of information. . The Liver Disease Research Branch within the Division of Digestive Diseases and Nutrition of the National Institute of Diabetes and Digestive and Kidney Diseases (referred to in this subsection as the Liver Disease Research Branch ) is hereby redesignated and promoted as the Division of Liver Diseases, which shall be within the National Institute of Diabetes and Digestive, Kidney, and Liver Diseases, as redesignated by subsection (a), as a separate division from the other divisions within such Institute. Section 428 of the Public Health Service Act ( 42 U.S.C. 285c–2 ) is amended— in the section heading, by striking and inserting Division directors for diabetes, endocrinology, and metabolic diseases, digestive diseases and nutrition, and kidney, urologic, and hematologic diseases ; Division directors for diabetes, endocrinology, and metabolic diseases, digestive diseases and nutrition, kidney, urologic, and hematologic diseases, and liver diseases in subsection (a)(1)— in the matter preceding subparagraph (A), by striking and a Division Director for Kidney, Urologic, and Hematologic Diseases and inserting a Division Director for Kidney, Urologic, and Hematologic Diseases, and a Division Director for Liver Diseases ; and in subparagraph (A), by striking and kidney, urologic, and hematologic diseases and inserting kidney, urologic, and hematologic diseases, and liver diseases ; and in subsection (b)— in the matter preceding paragraph (1), by striking and the Division Director for Kidney, Urologic, and Hematologic Diseases and inserting the Division Director for Kidney, Urologic, and Hematologic Diseases, and the Division Director for Liver Diseases ; and in paragraph (1), by striking and kidney, urologic, and hematologic diseases and inserting kidney, urologic, and hematologic diseases, and liver diseases . The individual serving as the Director of the Liver Disease Research Branch as of the date of enactment of this Act may continue to serve as the Division Director for Liver Diseases commencing as of that date. The Secretary of Health and Human Services shall delegate to the Division Director for Liver Diseases all duties and authorities that were vested in the Director of the Liver Disease Research Branch as of the day before the date of enactment of this Act. Any reference to the Liver Disease Research Branch, or the Director of the Liver Disease Research Branch, in any law, regulation, document, record, or other paper of the United States shall be deemed to be a reference to the Division of Liver Diseases, or the Division Director for Liver Diseases, respectively. Section 429(a) of the Public Health Service Act ( 42 U.S.C. 285c–3(a) ) is amended— in paragraph (1), by striking and kidney, urologic, and hematologic diseases and inserting kidney, urologic, and hematologic diseases, and liver diseases ; and in the matter following paragraph (2), by striking and a Kidney, Urologic, and Hematologic Diseases Coordinating Committee and inserting a Kidney, Urologic, and Hematologic Diseases Coordinating Committee, and a Liver Diseases Coordinating Committee . Section 430 of the Public Health Service Act ( 42 U.S.C. 285c–4 ) is amended— in subsection (a), by striking and the National Kidney and Urologic Diseases Advisory Board and inserting the National Kidney and Urologic Diseases Advisory Board, and the Liver Diseases Advisory Board ; and in subsection (b)(2)(A)(i)— by striking the Director of the National Institute of Diabetes and Digestive and Kidney Diseases and inserting the Director of the National Institute of Diabetes and Digestive, Kidney, and Liver Diseases ; and by striking and the Division Director of the National Institute of Diabetes and Digestive and Kidney Diseases and inserting and the Division Director of the National Institute of Diabetes and Digestive, Kidney, and Liver Diseases . Section 431 of the Public Health Service Act ( 42 U.S.C. 285c–5 ) is amended— by redesignating subsection
(e)as subsection (f); and by inserting after subsection
(d)the following new subsection: The Director of the Institute shall provide for the development or substantial expansion of centers for research in liver diseases. Each center developed or expanded under this subsection— shall utilize the facilities of a single institution, or be formed from a consortium of cooperating institutions, meeting such research qualifications as may be prescribed by the Secretary; shall develop and conduct basic and clinical research into the cause, diagnosis, early detection, prevention, control, and treatment of liver diseases and related functional, congenital, metabolic, or other complications resulting from such diseases; shall encourage research into and programs for— providing information for patients with such diseases and complications and the families of such patients, physicians and others who care for such patients, and the general public; model programs for cost effective and preventive patient care; and training physicians and scientists in research on such diseases and complications; and may perform research and participate in epidemiological studies and data collection relevant to liver diseases in order to disseminate such research, studies, and data to the health care profession and to the public. . Section 432 of the Public Health Service Act ( 42 U.S.C. 285c–6 ) is amended— by striking and a subcommittee on kidney, urologic, and hematologic diseases and inserting a subcommittee on kidney, urologic, and hematologic diseases, and a subcommittee on liver diseases ; and by striking and kidney, urologic, and hematologic diseases and inserting kidney, urologic, and hematologic diseases, and liver diseases .
Connectionstraces to 3
6 references not yet in our index
- 42 USC 285c–1
- 42 USC 285c–2
- 42 USC 285c–3(a)
- 42 USC 285c–4
- 42 USC 285c–5
- 42 USC 285c–6
Citation graph
cites case law
Sec. 6
Changes relating to National Institute of Diabetes and Digestive and Kidney Diseases
Cite42 USC 285c–1
Cite42 USC 285c–2
Cite42 USC 285c–3(a)
Cite42 USC 285c–4
Cite42 USC 285c–5
Cites 9 · showing 8Cited by 0 across 0 sources